Omeprazol Ratiopharm (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Ratiopharm, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease.

GNH USA supplies Omeprazol Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on the gastric parietal cell to lower acid production, making it useful for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Peptic ulcer disease: facilitates ulcer healing by maintaining a less acidic gastric environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors. - Erosive oesophagitis: promotes mucosal repair and reduces further injury.

Adverse reactions may occur with any medication and should be monitored by a healthcare professional.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually transient. - Nausea: occasional and self‑limiting. - Abdominal pain: mild discomfort. - Flatulence: increased gas production. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Acute interstitial nephritis: renal inflammation. - Hypomagnesemia: low serum magnesium levels. - Stevens‑Johnson syndrome: severe skin reaction. - Hepatic injury: elevated liver enzymes. - Fracture risk: possible reduced bone density with long‑term use.

Before initiating therapy, consider patient‑specific factors and potential risks. - Renal impairment: adjust use in severe kidney disease. - Hepatic disease: monitor liver function in patients with liver disorders. - Concomitant medications: review for drugs that may interact with acid suppression. - Long‑term therapy: assess need for calcium, vitamin B12, and magnesium supplementation. - Pregnancy and lactation: evaluate risk‑benefit ratio with the prescriber. - Store below 25°C: keep in the original pack, protect from moisture.

Omeprazole can affect the pharmacokinetics of several medicines; awareness of interaction severity helps guide safe co‑administration.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and antiviral efficacy. - Methotrexate (high dose): increased toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Diazepam: elevated plasma concentrations. - Digoxin: altered serum levels requiring monitoring.